01 144JANSSEN PHARMS
01 307943582
02 107943788
03 308222219
04 308513202
05 411576894
06 107943582*PED
07 107943788*PED
08 108222219*PED
09 108513202*PED
01 70Y
02 74Blank
01 74Y
02 70Blank
01 302025-04-11
02 102025-10-11
03 102027-07-14
04 302027-12-03
05 102028-01-14
06 102028-06-03
07 302029-02-26
08 102029-08-26
09 42030-07-06
Patent Expiration Date : 2029-02-26
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7943582
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2025-04-11
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8222219
Drug Substance Claim :
Drug Product Claim :
Application Number : 204353
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-11
Patent Expiration Date : 2029-02-26
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7943582
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2025-04-11
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8222219
Drug Substance Claim :
Drug Product Claim :
Application Number : 204353
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-11
Patent Expiration Date : 2025-04-11
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8222219
Drug Substance Claim :
Drug Product Claim :
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-04-11
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2029-02-26
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7943582
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2025-04-11
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8222219
Drug Substance Claim :
Drug Product Claim :
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-04-11
